II. Precautions
- This topic covers a general approach to Acute Leukemia and its diagnosis
- See specific Acute Leukemia types for the most updated information
III. Types
-
Acute Myelogenous Leukemia
- Most cases occur in adults
-
Acute Lymphocytic Leukemia (or Acute Lymphoblastic Leukemia)
- Most cases (80%) occur in children (esp. age <5 years)
- Remaining 20% of Acute Lymphoblastic Leukemia cases occur in age >50 years old
IV. Findings: Signs and Symptoms (within 3 months of presentation)
- Anemia symptoms and signs
- Bleeding symptoms and signs
- Gingival Bleeding
- Gastrointestinal Bleeding
- Petechiae
- Easy bruisability
- Hematologic findings other than bleeding (rare in adults)
- Infectious symptoms and signs
- Fever
- Cellulitis
- Gingiva infection
- Candida infection
- Pneumonia
- Perirectal Abscess
- Urinary Tract Infection
- Chloroma development in any location
- Soft Tissue Masses of leukemic cells
- Expanding cell mass symptoms (50%)
- Bone pain (spine and long bones) is present in 43% of children
- Sternal tenderness
- Renal related symptoms and signs
- Nephrolithiasis (Uric Acid stones)
- Urate nephropathy
V. Labs
- Complete Blood Count with differential (Pancytopenia)
-
Peripheral Smear
- Circulating blast cells may not be seen
- Chemistry panel (Chem 7)
-
Liver Function Tests
- Lactate Dehydrogenase (LDH) increased
VI. Imaging
- Bone XRay
- Osteopenia
- Metaphyseal bands
- Lytic lesions
- Sclerotic changes
- Bone destruction
VII. Diagnosis
-
General (both ALL and AML)
- Blast cell predominance
- However, blast cell absence on Peripheral Smear does not exclude Acute Leukemia
- Immunophenotyping (flow cytometry, cytogenetic testing) distinguishes between AML and ALL
- Blast cell predominance
-
Acute Lymphoblastic Leukemia
- Lymphoblasts represent >20% of cells in Bone Marrow sample
- Also obtain Lumbar Puncture for CSF
-
Acute Myelogenous Leukemia
- Myeloblasts represent >20% of cells in Bone Marrow or peripheral blood sample
- Auer rods on Peripheral Smear (not often found)
- Also obtain Lumbar Puncture for AML patients if undergoing intrathecal therapy
VIII. Management: Remission
- Goal
- Criteria for Remission
- Less then 5 percent blast cells in Bone Marrow
- Leukemic cells absent in Bone Marrow
- Normal peripheral blood cell counts Restored
- Signs of extramedullary Leukemia involvement absent
- Overall Management Strategy
- Step 1: Remission Induction Chemotherapy
- Intensive systemic Chemotherapy
- Drives leukemic cell mass below detectable level
- Step 2: Early Intensification (Consolidation)
- Intensive Chemotherapy after Remission Induction
- Further reduce and possibly eradicate Leukemia
- Step 3: Maintenance
- Lower dose Chemotherapy continued over years
- Step 4: Late Intensification
- Intensive Chemotherapy restarted after 6 months
- Step 5: Local elimination of common relapse sites
- Local Chemotherapy or radiation to sanctuary sites
- Step 1: Remission Induction Chemotherapy
IX. Management: Supportive care of Pancytopenia
-
Anemia
- Treat with packed Red Blood Cell Transfusion
-
Thrombocytopenia
- Keep Platelet Count above 20 x 10^9/L
- Platelet Transfusion effective initially
- Antiplatelet Antibody develops over time
- Shortens Platelet survival
- Render patient unresponsive to transfusion
- May respond to HLA Identical Platelets
-
Granulocytopenia (Neutropenia)
- Granulocyte transfusions not recommended
- Prevent infection
- Reverse isolation rooms
- Face Masks
- Careful Hand Washing
- Observation for Bacterial and fungal infection
X. Complications
-
Leukostasis
- Occurs when circulating blasts > 100 x10^9/L
- Examples
- Lung hypoperfusion
- Brain hypoperfusion
-
Thrombocytopenia related bleeding complications
- Occurs when Platelet Count < 20 x10^9/L
- Examples
-
Neutropenia related infections
- Occurs when Neutrophil Count < 0.5 x10^9/L
- Examples
- Gram NegativeSepsis
- Candida infection